UK markets close in 1 hour 21 minutes
  • FTSE 100

    7,337.80
    +14.39 (+0.20%)
     
  • FTSE 250

    19,066.08
    -285.19 (-1.47%)
     
  • AIM

    897.26
    -10.35 (-1.14%)
     
  • GBP/EUR

    1.1553
    -0.0022 (-0.19%)
     
  • GBP/USD

    1.2121
    -0.0063 (-0.52%)
     
  • BTC-GBP

    16,585.01
    -822.32 (-4.72%)
     
  • CMC Crypto 200

    433.72
    -5.94 (-1.35%)
     
  • S&P 500

    3,827.73
    +6.18 (+0.16%)
     
  • DOW

    31,069.24
    +122.25 (+0.40%)
     
  • CRUDE OIL

    113.59
    +1.83 (+1.64%)
     
  • GOLD FUTURES

    1,818.70
    -2.50 (-0.14%)
     
  • NIKKEI 225

    26,804.60
    -244.87 (-0.91%)
     
  • HANG SENG

    21,996.89
    -422.08 (-1.88%)
     
  • DAX

    13,056.07
    -175.75 (-1.33%)
     
  • CAC 40

    6,047.63
    -38.39 (-0.63%)
     

Olink to participate in the 43rd Annual Goldman Sachs Global Healthcare Conference

  • Oops!
    Something went wrong.
    Please try again later.
·1-min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
Olink Proteomics AB
Olink Proteomics AB

UPPSALA, Sweden, June 01, 2022 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK), today announced its participation in the 43rd Annual Goldman Sachs Global Healthcare Conference.

Company management will participate in a fireside chat on Tuesday, June 14th, 2022, at 2:00 pm PT / 5:00 pm ET.

A live and archived webcast of the event will be available on the “Investors” section of the Company’s website at https://investors.olink.com/investor-relations.

About Olink
Olink Holding AB (Nasdaq: OLK) is a company dedicated to accelerating proteomics together with the scientific community, across multiple disease areas to enable new discoveries and improve the lives of patients. Olink provides a platform of products and services which are deployed across major biopharmaceutical companies and leading clinical and academic institutions to deepen the understanding of real-time human biology and drive 21st century healthcare through actionable and impactful science. The company was founded in 2016 and is well established across Europe, North America, and Asia. Olink is headquartered in Uppsala, Sweden.

Investor Contact
Jan Medina, CFA
VP Investor Relations & Capital Markets
Mobile: +1 617 802 4157
jan.medina@olink.com

Media Contact
Andrea Prander
Corporate Communications Manager
Mobile: +46 768 775 275
andrea.prander@olink.com


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting